Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
19972.1k citationsJan A. Staessen, Robert Fagard et al.The Lancetprofile →
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
19981.0k citationsFrançoise Forette, Marie‐Laure Seux et al.The Lancetprofile →
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
1999662 citationsJaakko Tuomilehto, Daiva Rastenytė et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by W. H. Birkenhäger
Since
Specialization
Citations
This map shows the geographic impact of W. H. Birkenhäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. H. Birkenhäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. H. Birkenhäger more than expected).
Fields of papers citing papers by W. H. Birkenhäger
This network shows the impact of papers produced by W. H. Birkenhäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. H. Birkenhäger. The network helps show where W. H. Birkenhäger may publish in the future.
Co-authorship network of co-authors of W. H. Birkenhäger
This figure shows the co-authorship network connecting the top 25 collaborators of W. H. Birkenhäger.
A scholar is included among the top collaborators of W. H. Birkenhäger based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W. H. Birkenhäger. W. H. Birkenhäger is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Chalmers, John, et al.. (2004). Hypertension in the twentieth century: concepts and achievements. Elsevier eBooks. 22.5 indexed citations
3.
Chalmers, John, Justin Chapman, Alberto Zanchetti, W. H. Birkenhäger, & James Robertson. (2004). Development of blood pressure lowering therapy from trials to practice.3 indexed citations
4.
Staessen, Jan A., Ji‐Guang Wang, Giuseppe Bianchi, & W. H. Birkenhäger. (2003). Essential hypertension. The Lancet. 361(9369). 1629–1641.322 indexed citations
Staessen, Jan A., et al.. (1999). Controversy. European Heart Journal. 20(1). 11–30.13 indexed citations
8.
Seux, Marie‐Laure, F Forette, Jan A. Staessen, et al.. (1999). Treatment of isolated systolic hypertension and dementia prevention in older patients: Results of the Systolic Hypertension in Europe Trial (SYST-EUR) vascular dementia project. European Heart Journal Supplements. 1.3 indexed citations
9.
Tuomilehto, Jaakko, Daiva Rastenytė, W. H. Birkenhäger, et al.. (1999). Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension. New England Journal of Medicine. 340(9). 677–684.662 indexed citations breakdown →
Birkenhäger, W. H., et al.. (1978). Circulating catecholamines and blood pressure.25 indexed citations
17.
Amery, A., P Berthaux, W. H. Birkenhäger, et al.. (1978). Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE).. PubMed. 33(2). 113–34.35 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.